| CRISPR Medicine | This is an overview of all our articles
The FDA has granted orphan drug and rare pediatric disease designations to Arbor Biotechnologies' ABO-101, a gene-editing therapeutic candidate for...
Some of the best links we picked up around the internet
Focused ultrasound (FUS) can significantly improve the efficiency of CRISPR-based genome editing in the brain, according to a new study from the...
CRISPRMED25 is an event not to be missed, but don't take it from us! Hear what some of CRISPRMED24 attendees have to say about the conference in this...
In a recent CMN Live session, we spoke with Eligo Bioscience CEO Xavier Duportet about the human microbiome, its role in health and disease, and how...
The FDA has cleared Allogene Therapeutics' IND application for ALLO-329, a novel dual-targeting CAR T cell therapy designed to treat multiple...